Zobrazeno 1 - 10
of 97
pro vyhledávání: '"Zihong Chen"'
Autor:
Haiqing Luo, Guihua Yi, Haifeng Tang, Lingli Chen, Liren Hu, Donghong Yang, Zihong Chen, Haiwen Li, Dechao Zhan, Ying Yu, Ying Zeng, Yilin Cai, Jiayuan Wu, Huafeng Liu
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Cisplatin is the most commonly used platinum-based treatment for nasopharyngeal carcinoma (NPC). However, its clinical application is limited owing to its nephrotoxicity and gastrointestinal reactions. Proton pump inhibitors (PPIs) have been
Externí odkaz:
https://doaj.org/article/1b78d1355d974d0281bcab3744f3091f
Autor:
Lifang Li, Danyang Li, Jingnan Jin, Fanfan Xu, Ni He, Yingjie Ren, Xiaokun Wang, Liting Tian, Biying Chen, Xiaoju Li, Zihong Chen, Lanxin Zhang, Lukuan Qiao, Lihua Wang, Jianjian Wang
Publikováno v:
Journal of Neuroinflammation, Vol 21, Iss 1, Pp 1-17 (2024)
Abstract Background Myasthenia gravis (MG) is an autoimmune disease characterized by pathogenic antibodies that target structures of the neuromuscular junction. The evidence suggests that the regulation of long noncoding RNAs (lncRNAs) that is mediat
Externí odkaz:
https://doaj.org/article/1518a2690e65474c8442ea909590c188
Autor:
Jiaqi He, Guoqing Luo, Shen Liu, Lingli Chen, Zihong Chen, Bing Zhang, Jiong Lin, Wenyi Qin, Haiwen Li, Haideng Zhou, Ying Yu, Dechao Zhan, Donghong Yang, Haiqing Luo
Publikováno v:
Translational Oncology, Vol 48, Iss , Pp 102058- (2024)
Background: The efficacy of immunotherapy plus neoadjuvant chemotherapy and concurrent chemoradiotherapy (CCRT) for locally advanced nasopharyngeal carcinoma (LA-NPC) has not been reported. This study retrospectively compared the efficacy of tisleliz
Externí odkaz:
https://doaj.org/article/34a5e69d0aaa45278d794127bcdfef9e
Autor:
Yaxiong Zhang, Zihong Chen, Yu Liu, Liang Han, Wei Jiang, Qiming Wang, Jianhua Shi, Liqin Lu, Jianying Li, Mingjun Zhang, Yan Huang, Yunpeng Yang, Xue Hou, Li Zhang, Jing Li, Wenfeng Fang, Gang Chen
Publikováno v:
Cancer Medicine, Vol 13, Iss 7, Pp n/a-n/a (2024)
Abstract Background Combination of chidamide and anti‐PD‐L1 inhibitor produce synergistic anti‐tumor effect in advanced NSCLC patients resistant to anti‐PD‐1 treatment. However, the effect of chidamide plus envafolimab has not been reported
Externí odkaz:
https://doaj.org/article/578cd829c078423493f02155175529a1
Autor:
Jing Lai, Peixin Lin, Jiafeng Zhuang, Zhiwei Xie, Hechao Zhou, Donghong Yang, Zihong Chen, Danxian Jiang, Jing Huang
Publikováno v:
Cancer Medicine, Vol 13, Iss 7, Pp n/a-n/a (2024)
Abstract Background Inflammatory markers, including the product of neutrophil count, platelet count, and monocyte count divided by lymphocyte count (PIV) and the platelet‐to‐white blood cell ratio (PWR), have not been previously reported as progn
Externí odkaz:
https://doaj.org/article/39092ab232a54f94af5d10c7b556f073
Publikováno v:
Shipin gongye ke-ji, Vol 44, Iss 8, Pp 244-251 (2023)
The application scope of antioxidant peptides is limited due to their bitter taste, easy to moisture absorption, difficult to preservation, and easy to loss of activity during processing. In order to enrich its product form, the preparation technolog
Externí odkaz:
https://doaj.org/article/784ba18f32a9421d844deabf38900981
Publikováno v:
Nursing Open, Vol 10, Iss 3, Pp 1526-1535 (2023)
Abstract Aim To examine the association between the hospitalization time and fall incidence. Design A secondary analysis using the Dryad Digital Repository public database. Methods Data were extracted from the Fukushima Medical University Hospital co
Externí odkaz:
https://doaj.org/article/1bcbe02ad0e34ddc9f46f8a381394964
Publikováno v:
Metals, Vol 13, Iss 3, p 441 (2023)
Increasing the use of steel scrap and enhancing its recycling utilization are important strategies for fostering the low-carbon and environmental-friendly growth of the iron and steel industry in China. However, the current steelmaking processes cann
Externí odkaz:
https://doaj.org/article/2ad5aaab6e56415ea2328cd14bebd834
Publikováno v:
Emergency Medicine International, Vol 2022 (2022)
Objective. To explore the clinical efficacy and safety of apatinib combined with paclitaxel in the first-line treatment of locally advanced nasopharyngeal carcinoma. Methods. From March 2016 to June 2018, 114 patients with locally advanced nasopharyn
Externí odkaz:
https://doaj.org/article/cfba5c5388ac422590cbff24a5546026
Publikováno v:
Ironmaking & Steelmaking. :1-6